Foto: Erik Cronholm.

Stockholm Life Tech gets full funding

Stockholm Life Tech is awarded over SEK 16 million from the European Regional Development Fund. The project is run by Region Stockholm and will enable advanced development and production environments in Flemingsberg to be opened to small and medium-sized companies.

In Flemingsberg, it is primarily ANA Futura and Vecura that are opened to more small and medium-sized companies working on advanced therapies. Something that can support the growth of small and medium-sized companies in life science.

Stockholm Life Tech is run by the Stockholm Region to further develop and make available research and innovation infrastructures in the region. The work will be conducted in three different blocks and nine defined work packages.

Sustainability aspects should permeate the project, for example when selecting companies. Activities that are planned to be carried out include, for example, mentoring groups and women’s networks.

Stockholm Life Tech will result in an increased interest in investing and setting up Life Science companies in the region. The project is ongoing until 2023.

More project that have recieved funding (in Swedish)

“Soon we can meet again IRL”

Since the Covid outbreak, our work has been characterised by video meetings, especially in our various focus groups. Success has exceeded expectations, thanks to the fact that the approximately 70 people who are involved in the groups had time to get to know one other and the issues even before the pandemic. But we are really looking forward to being able to meet again IRL, and hopefully soon – it is so much more enjoyable!

XNK Therapeutics lays the groundwork for GMP facility in Flemingsberg

"Flemingsberg is the place in the world you want to be if you work with NK cells. There is a strong research facility here with a world-leading research group and proximity to a clinic that really knows NK cells. We recently started the construction of a new GMP facility with an associated research laboratory of 350 square meters for our NK cell therapy. The new facility is being built at Novum in Flemingsberg and, once the facility is completed in 2022, it will give us complete control over the entire development chain."

Want to know more?
Subscribe to our newsletter.

SUBSCRIBE

Want to know more?
Subscribe to our newsletter.

SUBSCRIBE
CF_logo_neg
2021-03-09T11:45:19+01:00
Go to Top